Integra LifeSciences Holdings Corporation (IART)
NASDAQ: IART · Real-Time Price · USD
13.23
-0.34 (-2.51%)
At close: Dec 5, 2025, 4:00 PM EST
13.25
+0.02 (0.15%)
After-hours: Dec 5, 2025, 7:52 PM EST
IART Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for IART stock ranges from a low of $11 to a high of $25. The average analyst price target of $15 forecasts a 13.38% increase in the stock price over the next year.
Price Target: $15.00 (+13.38%)
Analyst Consensus: Hold
* Price targets were last updated on Nov 3, 2025.
Analyst Ratings
The average analyst rating for IART stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 2 | 3 | 3 |
| Sell | 3 | 3 | 3 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 9 | 9 | 9 | 6 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Hold Reiterates $15 → $13 | Hold | Reiterates | $15 → $13 | -1.74% | Nov 3, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $12 → $11 | Strong Sell | Maintains | $12 → $11 | -16.86% | Oct 31, 2025 |
| JP Morgan | JP Morgan | Sell Maintains $12 → $13 | Sell | Maintains | $12 → $13 | -1.74% | Oct 31, 2025 |
| Truist Securities | Truist Securities | Hold Maintains $13 → $15 | Hold | Maintains | $13 → $15 | +13.38% | Oct 15, 2025 |
| Citigroup | Citigroup | Strong Sell Maintains $10 → $12 | Strong Sell | Maintains | $10 → $12 | -9.30% | Oct 7, 2025 |
Financial Forecast
Revenue This Year
1.66B
from 1.61B
Increased by 3.26%
Revenue Next Year
1.71B
from 1.66B
Increased by 2.71%
EPS This Year
2.24
from -0.09
EPS Next Year
2.40
from 2.24
Increased by 7.03%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.7B | 1.8B | ||
| Avg | 1.7B | 1.7B | ||
| Low | 1.6B | 1.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 6.6% | 7.3% | ||
| Avg | 3.3% | 2.7% | ||
| Low | -1.0% | -2.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.33 | 2.68 | ||
| Avg | 2.24 | 2.40 | ||
| Low | 2.13 | 2.22 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 19.3% | ||
| Avg | - | 7.0% | ||
| Low | - | -0.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.